A Precision-Based Approach for Bioactive Skin Allograft Application in Nonhealing Wounds Using Bacterial Fluorescence Imaging

A Precision-Based Approach for Bioactive Skin Allograft Application in Nonhealing Wounds Using Bacterial Fluorescence Imaging

This peer-reviewed case series addresses the clinical challenge of managing chronic, nonhealing wounds using advanced modalities – specifically, bioactive skin allografts (BSAs). BSAs are cellular and/or tissue-based products (CTPs) designed to promote tissue repair by supporting angioenesis, cellular proliferation, and immune modulation. A key innovation discussed is the use of bacterial fluorescence imaging (FL-imaging), a…

Learn More

Reducing Unwarranted Clinical Variability Visit Frequency 2.0

Reducing Unwarranted Clinical Variability Visit Frequency 2.0

As part of the People-first, Patient-centered focus, Healogics® is dedicated to continuously improving patient outcomes. A process was developed to identify and evaluate critical topics to determine the levers which would result in reducing unwarranted clinical variability across our organization and improve Comprehensive Healing Rates (CHR) amongst our patients. Four levers were identified utilizing the…

Learn More

The Use of Modalities in Wound Care Part 1: Debridement

The Use of Modalities in Wound Care Part 1: Debridement

In this white paper, we will review the use of modalities as a lever for reducing unwarranted clinical variability. This is the fourth in a series of white papers that have tried to provide evidence and clinical guidance for providers managing complex wound patients. As in all previous white papers, the literature has been reviewed, the data has been updated and refreshed using a 2019 research database from Healogics and recommendations have been formulated for consideration.

Learn More

The Impact of Stalled Wounds on Patient Outcomes

The Impact of Stalled Wounds on Patient Outcomes

Recently, we introduced four levers that could improve our patient outcomes. These levers included frequent patient visits, the prevention of stalled wounds, improving patient engagement and utilizing advanced modalities. The focus of this paper will be on the evidence and research supporting the key lever of preventing stalled wounds in driving better patient outcomes.

Learn More

Development of a Model to Predict Healing of Chronic Wounds Within 12 Weeks

Development of a Model to Predict Healing of Chronic Wounds Within 12 Weeks

Researchers from the University of Southern California (USC) in partnership with Healogics have recently produced a predictive model to identify wounds most likely to heal within 12 weeks. Unlike other models that have been previously published, this model utilized EMR data from over 600,000 wounds, allowing for highly predictive classification across a variety of wound types. Findings from this model also indicated that a wound’s characteristics at initial presentation, such as area, depth, and location, are far more powerful than the patient demographics or comorbidities in determining whether a wound will heal.

Learn More

Reducing Amputations in the Community

Reducing Amputations in the Community

Healogics assessed the impact of a collaborative continuum of care model between a Wound Care Center® and vascular surgery practice on quality of care and outcomes. Of the 7,616 procedures that were reviewed by Stanford Health Care’s Vascular & Endovascular Surgery practice, 1,751 procedures met inclusion criteria. This study included patients who underwent lower extremity interventions over a three-year period before and after the opening of a Wound Care Center.

Learn More

Diagnosis and Management of Diabetic Foot Infections

Diagnosis and Management of Diabetic Foot Infections

This compendium is a follow-up to the 2018 American Diabetes Association compendium Diagnosis and Management of Diabetic Foot Complications. Whereas the first compendium offered a broad general overview of diabetic foot conditions, this second volume presents a detailed discussion of the prevention and treatment of diabetic foot infections (DFIs), a major contributor to high amputation rates among people with diabetes.

Learn More